Evidence map›Paper›PMID 24854003›Full record

ArticleChest2015

A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions.

Anthony F Boyer, Noah Schoenberg, Hilary Babcock, Kathleen M McMullen, Scott T Micek, Marin H Kollef

Abstract read
PubMed Publisher
In one paragraph

Article in Chest, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anthony F BoyerDivision of Pulmonary and Critical Care Medicine, Division of Infectious Diseases, Washington University School of Medicine.
Noah SchoenbergDivision of Pulmonary and Critical Care Medicine, Division of Infectious Diseases, Washington University School of Medicine.
Hilary BabcockDivision of Pulmonary and Critical Care Medicine, Division of Infectious Diseases, Washington University School of Medicine.
Kathleen M McMullenHospital Epidemiology and Infection Prevention Department, Barnes-Jewish Hospital.
Scott T MicekSt. Louis College of Pharmacy, St. Louis, MO.
Marin H KollefDivision of Pulmonary and Critical Care Medicine, Division of Infectious Diseases, Washington University School of Medicine. Electronic address: mkollef@dom.wustl.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Centers for Disease Control and Prevention has shifted policy away from using ventilator-associated pneumonia (VAP) and toward using ventilator-associated conditions (VACs) as a marker of ICU quality. To date, limited prospective data regarding the incidence of VAC among medical and surgical ICU patients, the ability of VAC criteria to capture patients with VAP, and the potential clinical preventability of VACs are available.

methodsThis study was a prospective 12-month cohort study (January 2013 to December 2013).

resultsWe prospectively surveyed 1,209 patients ventilated for ≥ 2 calendar days. Sixty-seven VACs were identified (5.5%), of which 34 (50.7%) were classified as an infection-related VAC (IVAC) with corresponding rates of 7.0 and 3.6 per 1,000 ventilator days, respectively. The mortality rate of patients having a VAC was significantly greater than that of patients without a VAC (65.7% vs 14.4%, P < .001). The most common causes of VACs included IVACs (50.7%), ARDS (16.4%), pulmonary edema (14.9%), and atelectasis (9.0%). Among IVACs, 44.1% were probable VAP and 17.6% were possible VAP. Twenty-five VACs (37.3%) were adjudicated to represent potentially preventable events. Eighty-six episodes of VAP occurred in 84 patients (10.0 of 1,000 ventilator days) during the study period. The sensitivity of the VAC criteria for the detection of VAP was 25.9% (95% CI, 16.7%-34.5%).

conclusionsAlthough relatively uncommon, VACs are associated with greater mortality and morbidity when they occur. Most VACs represent nonpreventable events, and the VAC criteria capture a minority of VAP episodes.

Indexed as

Quality Assurance, Health CareAdultAgedFemaleFollow-Up StudiesHumansIntensive Care UnitsMaleMiddle AgedMorbidityPneumonia, Ventilator-AssociatedProspective StudiesRespiration, ArtificialSurvival RateUnited States

Identifiers

PMID24854003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.